Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00898391 · ClinicalTrials.gov registry record
Study of DNA in Blood Samples From Patients With Neuroblastoma
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 329
- Enrollment target
NCT00898391: Completed study, sponsored by Children's Oncology Group.
NCT00898391 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 329 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00898391 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 329 participants
- Enrollment target
Study Summary
This research trial studies is deoxyribonucleic acid (DNA) in blood samples from patients with neuroblastoma. Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment.
Interventions
- OTHER laboratory biomarker analysis
- GENETIC polymerase chain reaction
- GENETIC DNA analysis
- GENETIC polyacrylamide gel electrophoresis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 329 participants |
| Start Date | 2007-06 |
| Est. Completion | 2016-05 |
What the finished NCT00898391 record still lists
NCT00898391 is an observational study that tracks outcomes without assigning an intervention. The registered 329 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 4 interventions - of which laboratory biomarker analysis is the first listed.
NCT00898391 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00898391 about?
NCT00898391 is a clinical study titled "Study of DNA in Blood Samples From Patients With Neuroblastoma". This research trial studies is deoxyribonucleic acid (DNA) in blood samples from patients with neuroblastoma. Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help ...
What is the current status of trial NCT00898391?
This trial is currently completed. The enrollment target is 329 participants. The study started on 2007-06. Estimated completion is 2016-05.
What interventions are being tested in trial NCT00898391?
The interventions under investigation include: laboratory biomarker analysis (OTHER), polymerase chain reaction (GENETIC), DNA analysis (GENETIC), polyacrylamide gel electrophoresis (GENETIC).
Who is sponsoring clinical trial NCT00898391?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06036446 · 329 participants · NA
LATe Cerclage in High-risk Pregnancies (LATCH)
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia